These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11547604)

  • 41. Learning to use a new drug--the fast-acting insulin analogues.
    Amiel SA
    Diabet Med; 1998 Jul; 15(7):537-8. PubMed ID: 9686692
    [No Abstract]   [Full Text] [Related]  

  • 42. [Flexibility and effectiveness of diabetes therapy].
    Krankenpfl J; 2005; 43(1-3):62. PubMed ID: 15912849
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diabetes].
    Gerber P
    Rev Med Suisse; 2005 Jan; 1(2):125-8. PubMed ID: 15773212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The desirable insulin preparations from the viewpoint of insulin secretory dynamics].
    Kawamori R
    Nihon Rinsho; 2001 Nov; 59(11):2117-26. PubMed ID: 11712395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insulin.
    Panesar P
    Prof Nurse; 2004 Dec; 20(4):51-2. PubMed ID: 15624624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can involving diabetes specialists in developing a new insulin pen result in patient benefits?
    Koivisto V; Chatterton N; Hicks D; Bates PC; Llewelyn JA
    Diabetes Nutr Metab; 1999 Oct; 12(5):301-5. PubMed ID: 10741342
    [No Abstract]   [Full Text] [Related]  

  • 47. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-acting insulin analogs: progressing slowly].
    Geelhoed-Duijvestijn PH
    Ned Tijdschr Geneeskd; 2004 Nov; 148(45):2248; author reply 2248-9. PubMed ID: 15568634
    [No Abstract]   [Full Text] [Related]  

  • 49. Two minutes with diabetes.
    Whitehouse FW
    Med Times; 1977 Mar; 105(3):85-6. PubMed ID: 846331
    [No Abstract]   [Full Text] [Related]  

  • 50. [A new long-acting insulin analog. "Fewer hypoglycemias observed"].
    Gallwitz B
    MMW Fortschr Med; 2004 Jan; 146(3-4):47. PubMed ID: 15035450
    [No Abstract]   [Full Text] [Related]  

  • 51. New insulins in the treatment of diabetes mellitus.
    Lindholm A
    Best Pract Res Clin Gastroenterol; 2002 Jun; 16(3):475-92. PubMed ID: 12079270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Insulin. A comparison of commercial preparations].
    Menz W
    Med Monatsschr Pharm; 2006 Mar; 29(3):97-100. PubMed ID: 16550883
    [No Abstract]   [Full Text] [Related]  

  • 53. [When oral antidiabetics are no longer enough. Tablets plus basal insulin].
    Meissner T
    MMW Fortschr Med; 2001 Aug; 143(31-32):46. PubMed ID: 11556193
    [No Abstract]   [Full Text] [Related]  

  • 54. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy.
    Golightly LK; Jones MA; Hamamura DH; Stolpman NM; McDermott MT
    Pharmacotherapy; 2006 Oct; 26(10):1421-32. PubMed ID: 16999652
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experience with use of normal and superdep swine and cattle insulin].
    Sieberová R
    Vnitr Lek; 1972 Mar; 18(3):265-8. PubMed ID: 5062437
    [No Abstract]   [Full Text] [Related]  

  • 56. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Widened indications. More latitude with insulin analogs].
    MMW Fortschr Med; 2003 Sep; 145(39):52. PubMed ID: 14649078
    [No Abstract]   [Full Text] [Related]  

  • 58. Dosage response curve misleading.
    Grapp RF
    Am Fam Physician; 1971 Apr; 3(4):31. PubMed ID: 5550333
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety.
    Rolla A
    Am J Med; 2008 Jun; 121(6 Suppl):S9-S19. PubMed ID: 18514090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Insulin specialities. A survey of insulin specialities registrated in Norway January 1, 1973].
    Jervell J
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1618-9. PubMed ID: 4797697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.